Reading the tape
NASDAQ: TEM
Tempus AI, Inc.
Healthcare · Medical - Healthcare Information Services
Market Cap
$9.73B
52w High
$104.32
52w Low
$41.73
P/E
-39.69
Volume
4.08M
Outstanding Shares
174.36M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 3.22%Revenue (TTM): 83.41%FCF (TTM): -91.31%
What changed
The stock rose 3.22% over the last year. Revenue grew 83.41% over the trailing twelve months. Operating margin moved from -99.67% to -18.76%. Free cash flow declined 91.31% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at -18.76%. A decisive move in revenue — currently up 83.41% — would be the clearest signal to resolve the ambiguity.
Company profile
Tempus AI, Inc. operates as a healthcare technology company.
CEOEric Lefkofsky
SectorHealthcare
IndustryMedical - Healthcare Information Services
Employees2,400
IPO dateJun 14, 2024
Valuation
Forward P/E—
EV/EBITDA-47.23
Enterprise value$10.5B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth82.98%
Gross margin69.64%▲26.71%vs FY2024
Operating margin-18.76%▲81.17%vs FY2024
ROE-49.87%▲96.02%vs FY2024
Analyst consensus
RatingBuy
Target price$83.43▲49.49%
7
Buy
5
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est -$0.21 · Revenue est $345.44M
View